These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183 [No Abstract] [Full Text] [Related]
4. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology]. Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J; Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904 [No Abstract] [Full Text] [Related]
5. [Non-alcoholic fatty liver disease (NAFLD)]. Rau M; Weiss J; Geier A Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253 [TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease: a new epidemic in children. Ciocca M; Ramonet M; Álvarez F Arch Argent Pediatr; 2016 Dec; 114(6):563-569. PubMed ID: 27869416 [TBL] [Abstract][Full Text] [Related]
13. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A; J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212 [No Abstract] [Full Text] [Related]
14. Editors' Introduction to the NAFLD and NASH Special Issue. Fuchs M; Schnabl B Dig Dis Sci; 2016 May; 61(5):1211-3. PubMed ID: 27068170 [No Abstract] [Full Text] [Related]
15. Management of patients with non-alcoholic steatohepatitis (NASH) in real life. Serfaty L Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486 [TBL] [Abstract][Full Text] [Related]
16. Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality. Athyros VG; Doumas M Curr Vasc Pharmacol; 2018; 16(3):206-208. PubMed ID: 29598814 [No Abstract] [Full Text] [Related]
17. [[113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Non-alcoholic Fatty Liver Diseases and Non-alcoholic Steatohepatitis: Current Concepts]. Hashimoto E Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1753-60. PubMed ID: 30169948 [No Abstract] [Full Text] [Related]
18. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening. Middleton JP; Wiener RC; Barnes BH; Gurka MJ; DeBoer MD Clin Pediatr (Phila); 2014 Dec; 53(14):1318-25. PubMed ID: 24477713 [No Abstract] [Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic. Bernstein DE Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064 [No Abstract] [Full Text] [Related]
20. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease. Sanyal AJ; Mathurin P; Nagy LA Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520 [No Abstract] [Full Text] [Related] [Next] [New Search]